Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$63.75 - $108.06 $4.6 Million - $7.79 Million
72,080 New
72,080 $5.05 Million
Q1 2023

May 04, 2023

SELL
$33.36 - $45.71 $5.97 Million - $8.18 Million
-178,902 Reduced 48.22%
192,097 $6.76 Million
Q4 2022

Feb 03, 2023

BUY
$35.77 - $51.11 $2.83 Million - $4.04 Million
79,096 Added 27.1%
370,999 $17 Million
Q3 2022

Oct 25, 2022

BUY
$38.54 - $54.52 $6.37 Million - $9.01 Million
165,324 Added 130.61%
291,903 $14.1 Million
Q2 2022

Jul 29, 2022

BUY
$33.93 - $48.92 $4.29 Million - $6.19 Million
126,579 New
126,579 $4.97 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.66B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.